Design Therapeutics, Inc. announced the initiation of a Phase 1 clinical trial for its gene-targeted treatment DT-216P2 in healthy volunteers, with patient dosing for Friedreich Ataxia (FA) set to ...
R&D Expenses: Research and development (R&D) expenses were $13.4 million for the quarter ended December 31, 2025, and $59.1 million for the year ended December 31, 2025. G&A Expenses: General and ...
CARLSBAD, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, ...
Chipmakers must adopt transformative technologies including Digital Twins (DT) to keep pace with unprecedented global semiconductor industry growth that is expected to drive its total market value to ...
With more than 25 years of experience in mission critical construction and design, Lane Anderson has an extensive background in MEP projects and design and construction leadership. Having delivered ...
Medical device design and development is a process that helps to ensure devices that go to market are safe, effective, marketable, and profitable. The process is a blueprint of the phases needed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results